Fractyl Health faces Nasdaq delisting; plans hearing and reverse split

FRACTYL HEALTH, INC.

Nasdaq notified Fractyl Health on Sept 10, 2026 of delisting for failing minimum bid price rule.
Company intends to request hearing before Nasdaq Hearings Panel, which stays suspension.
Must maintain closing bid >= $1.00 for 10-20 consecutive days to regain compliance.
Proxy filed Aug 24, 2026 for reverse split ratio 1-for-5 to 1-for-15 to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.